Table 5. Interactive Effects of Potential Mediators in the Prediction of Depressive Symptoms from Randomization to 6 Month Follow-up.
Order of Entry | Predictor | B | beta | t | p | Cumulative R2 | F for Increment in R2 for set | df | Partial Correlation (pr) |
---|---|---|---|---|---|---|---|---|---|
1 | HRSD T2 | .39 | .24 | 1.34 | .19 | .06 | .19 | 1,34 | .08 |
2 | Δ EQ-Wider | 1.29 | .27 | 1.59 | .12 | .09 | 1.43 | 2,32 | ..10 |
Group | -1.35 | -.25 | -1.54 | .13 | -.24 | ||||
3 | Δ EQ-Wider x Group | 2.38 | 1.13 | .39 | .04 | .21 | 4.45* | 1,31 | .35 |
1 | HRSD T2 | .17 | .12 | .70 | .69 | .01 | .37 | 1,31 | .13 |
2 | Δ TMS-Curiosity | 1.38 | .37 | 2.07 | .05 | .08 | 1.26 | 2,29 | .36 |
Group | -.97 | -.20 | -1.22 | .23 | -.23 | ||||
3 | Δ TMS-Curiosity x Group | 2.30 | .48 | 2.70 | .01 | .19 | 7.30** | 1,28 | .45 |
Note.
p < 0.05;
p < 0.01;
p < 0.001
Note. EQ= Experiences Questionnaire, TMS= Toronto Mindfulness Scale, HRSD T2 = Hamilton Rating Scale for Depression, randomization session (pre-treatment). Group = Mindfulness Based Cognitive Therapy (MBCT), Medication, Placebo. Δ = standardized residualized change in mediator variable from randomization to post treatment (i.e., eight weeks). All analyses use depression severity (HRSD T3 6 months) as the outcome.